-
Pandemic Data: SCLC Survival Outcomes for Carboplatin Comparable to Cisplatin
10 Nov 2025 23:27 GMT
… -line treatment for small cell lung cancer (SCLC), especially limited-stage … (OS) and safety between cisplatin and carboplatin. Results were published … effect on SCLC treatment because cisplatin administration typically requires hospitalization because …
-
Impact of Oncology Nursing Interventions on Chemotherapy-Induced Toxicities in Lung Cancer Patients
05 Nov 2025 12:48 GMT
… Characteristics of Lung Cancer Patients with and … histologically confirmed lung cancer undergoing chemotherapy … cisplatin-based chemotherapy for non-small cell lung cancer: a meta-analysis. Lung Cancer … peripheral neuropathy in lung cancer treatment. Tumori. …
-
Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study
06 Nov 2025 14:09 GMT
… ovarian, gastric, and lung cancers, ANXA4 has been found … ANXA3 enhances cisplatin resistance in lung cancer by upregulating … ANXA3 facilitates cisplatin resistance of lung cancer cells via … chemoresistance to paclitaxel in lung cancer cells. Oncotarget. …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … , chemotherapeutic agents like cisplatin, paclitaxel, and docetaxel … CPT-NPs inhibited lung tumor growth by …
-
<![CDATA[Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer]]>
20 Oct 2025 00:54 GMT
… –mutated non–small cell lung cancer that developed epidermal growth … -mutated non–small cell lung cancer with epidermal growth factor … the curve 5 or cisplatin at 75 milligrams per … EGFR-mutant non–small cell lung cancer.
References
“Sacituzumab tirumotecan …
-
Prognostic Impact of Advanced Lung Cancer Inflammation Index (ALI) on Immunotherapy Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Post Hoc Analysis
08 Oct 2025 06:55 GMT
… inflammation. The Advanced Lung Cancer Inflammation Index (ALI … plus cisplatin versus fluorouracil plus cisplatin in recurrent … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. … mature neutrophils in lung cancer tissues impairs the …
-
Biomolecular Condensates: New Lung Cancer Therapeutic Targets
06 Oct 2025 20:53 GMT
… deubiquitinating enzyme USP42 in lung cancer. USP42 undergoes phase separation … in a majority of lung cancers, also participates in … small-molecule drugs like cisplatin, revealing how phase … :
Biomolecular condensates in lung cancer: from molecular mechanisms to …
-
Chidamide Boosts Lung Cancer Drug Sensitivity
03 Oct 2025 16:39 GMT
… pivotal target in lung cancer malignancy.
Lung cancer remains one … renewed hope against lung cancer’s notorious treatment … ferroptosis and cisplatin sensitivity of lung cancer cells through … ferroptosis and cisplatin sensitivity of lung cancer cells through …
-
<![CDATA[Understanding “Paradigm-Changing” Events in Small Cell Lung Cancer Care]]>
25 Sep 2025 16:12 GMT
… [NCT03043872]— carboplatin/etoposide or cisplatin/etoposide plus durvalumab [Imfinzi … the Study of Lung Cancer 2025 World Conference on Lung Cancer, the phase 1b … the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer; September 6 …
-
Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation
25 Sep 2025 08:23 GMT
… small cell lung cancer (NSCLC) cases among all lung cancer cases … , the prevalent treatments of lung cancer mainly include surgery, radiotherapy … kg, i.g. daily), cisplatin (CDDP, n=12, i … #47;mTOR pathway in lung cancer; oncogenic alterations, therapeutic …